rs1801708
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001957.4(EDNRA):c.-230G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.455 in 152,706 control chromosomes in the GnomAD database, including 20,327 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as protective (no stars).
Frequency
Genomes: 𝑓 0.46 ( 20282 hom., cov: 32)
Exomes 𝑓: 0.39 ( 45 hom. )
Consequence
EDNRA
NM_001957.4 5_prime_UTR
NM_001957.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.56
Publications
14 publications found
Genes affected
EDNRA (HGNC:3179): (endothelin receptor type A) This gene encodes the receptor for endothelin-1, a peptide that plays a role in potent and long-lasting vasoconstriction. This receptor associates with guanine-nucleotide-binding (G) proteins, and this coupling activates a phosphatidylinositol-calcium second messenger system. Polymorphisms in this gene have been linked to migraine headache resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EDNRA Gene-Disease associations (from GenCC):
- mandibulofacial dysostosis with alopeciaInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
- cystic fibrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.834 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.455 AC: 69175AN: 151974Hom.: 20229 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
69175
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.390 AC: 240AN: 616Hom.: 45 Cov.: 0 AF XY: 0.384 AC XY: 132AN XY: 344 show subpopulations
GnomAD4 exome
AF:
AC:
240
AN:
616
Hom.:
Cov.:
0
AF XY:
AC XY:
132
AN XY:
344
show subpopulations
African (AFR)
AF:
AC:
5
AN:
6
American (AMR)
AF:
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
2
East Asian (EAS)
AF:
AC:
4
AN:
12
South Asian (SAS)
AF:
AC:
165
AN:
396
European-Finnish (FIN)
AF:
AC:
3
AN:
6
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
55
AN:
184
Other (OTH)
AF:
AC:
6
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.456 AC: 69289AN: 152090Hom.: 20282 Cov.: 32 AF XY: 0.449 AC XY: 33403AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
69289
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
33403
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
34932
AN:
41512
American (AMR)
AF:
AC:
5199
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1287
AN:
3470
East Asian (EAS)
AF:
AC:
1669
AN:
5104
South Asian (SAS)
AF:
AC:
2107
AN:
4816
European-Finnish (FIN)
AF:
AC:
2560
AN:
10594
Middle Eastern (MID)
AF:
AC:
143
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20164
AN:
67982
Other (OTH)
AF:
AC:
918
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1482
2964
4447
5929
7411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1524
AN:
3478
ClinVar
Significance: protective
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Migraine, resistance to Benign:1
May 22, 2001
OMIM
Significance:protective
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.